Practical Use of Continuous Glucose Monitoring to Adjust Glucose‐Lowering Therapy in Hemodialysis Patients: A Case Series
The case series highlights the potential to rethink glucose monitoring in hemodialysis patients with diabetes and underlines the need for future studies evaluating CGM use in this population.
Authors
- Kirsten Nørgaard (ORCID: https://orcid.org/0000-0003-1620-8271)
- Tobias Bomholt (ORCID: https://orcid.org/0000-0003-0614-4761)
- Merete B. Christensen (ORCID: https://orcid.org/0000-0002-0095-5427)
- Mads Hornum (ORCID: https://orcid.org/0000-0002-0123-4007)
- Dea Haagensen Kofod (ORCID: https://orcid.org/0000-0003-0173-8456)
- Christine L. Meyer‐Olesen (ORCID: https://orcid.org/0000-0002-0201-9448)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Copenhagen University Hospital (DK)
Publication Details
- Journal
- Hemodialysis International
- Published
- 2025-09-21
- DOI
- https://doi.org/10.1111/hdi.70024
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Dexcom
- Novo Nordisk
- Augustinus Fonden
- Rigshospitalet
- Vifor Pharma
- Region Sjælland
- Helen og Ejnar Bjørnows Fond